Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03872739
Other study ID # 201704020124
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 8, 2016
Est. completion date October 2021

Study information

Verified date March 2019
Source Guangdong Academy of Medical Sciences
Contact Danqing Yu, Doctor
Phone 13631349257
Email gdydq100@126.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To Compare Intravenous and Oral Hydration of the Prevention for Contrast-induced Nephropathy in Elderly Patients Undergoing Intravenous Contrast-enhanced Computed Tomography.


Description:

The prospective multicenter randomized controlled clinical research discusses the comparison of oral and intravenous hydration for prevention of contrast-induced nephropathy in elderly patients with enhanced computed tomography, establishing a simple hydration proposal.


Recruitment information / eligibility

Status Recruiting
Enrollment 1368
Est. completion date October 2021
Est. primary completion date June 30, 2021
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria:

- Age>21

- informed consent

- Undergoing Intravenous Contrast-enhanced Computed Tomography

Exclusion Criteria:

- CT enhancement was not performed;

- Dialysis treatment of patients with end-stage renal failure or heart, kidney transplantation;

- Exposure to radioactive contrast medium within 48 hours prior to or within 72 hours of examination;

- Acute decompensated heart failure;

- Allergic to radioactive contrast agent;

- Be subjected to life - threatening trauma;

- Severe infection;

- Surgery was performed within 2 days of CT examination.

- Combined with multiple myeloma, urinary obstruction, aortic dissection

- Can cause acute kidney injury disease;

- Use of aminoglycosides and other nephrotoxic drugs 2 weeks before.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
enhanced computed tomography
undergoing enhanced computed tomography

Locations

Country Name City State
China Guangdong provincial people's hospital Guanzhou Guangdong

Sponsors (1)

Lead Sponsor Collaborator
Yu Danqing

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary CIN Compared with before examination, the increase of serum creatinine conforms to the diagnostic criteria of contrast induced nephropathy. 72hours
See also
  Status Clinical Trial Phase
Completed NCT00339989 - Cervical Cancer Early Endpoints and Determinants
Active, not recruiting NCT05580341 - Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9 Phase 3
Completed NCT01766284 - Study of the Diagnostic Efficacy of "Real Time" Niris 1300e Optical Coherence Tomography (OCT) Imaging System in the Management of Pre-invasive and Invasive Neoplasia of the Uterine Cervix N/A
Completed NCT02363244 - Pap and HPVDNA Before and After Acetic Acid
Recruiting NCT02116920 - HPV E6/E7 mRNA Versus HPV DNA as Triage for Cervical Cancer Screening N/A
Enrolling by invitation NCT01836588 - New Gentle Biopsy Method of Cervix Lesions Using Superficial Curettage/Protocol ID: CX-CUR N/A
Completed NCT00289029 - A Study of Two Iodinated Contrast Agents in Renally Impaired Patients Undergoing Cardiac Angiography Phase 4
Recruiting NCT06261879 - Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer--ACTN4 and Other Biomarkers in Menstrual Blood N/A
Completed NCT03239223 - Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection Phase 1
Completed NCT03791606 - Risk Factors,PREvention and OutComes for CI-AKI in PatientS undErgoing PCI at Intensive Care Unit(PRECISE-ICU)
Completed NCT04809727 - Histopathological Findings in Symptomatizing Patients After Supracervical Hysterectomy N/A